Insufficient scRNA-seq data for expression of NOMO3 at single-cell level.
Insufficient scRNA-seq data for expression of NOMO3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 96% | 325.99 | 1736 / 1809 | 69% | 1.95 | 327 / 472 |
stomach | 95% | 270.37 | 342 / 359 | 70% | 1.69 | 200 / 286 |
esophagus | 90% | 199.57 | 1296 / 1445 | 75% | 1.97 | 137 / 183 |
lung | 94% | 258.79 | 544 / 578 | 70% | 1.67 | 806 / 1155 |
breast | 95% | 223.29 | 438 / 459 | 68% | 1.90 | 755 / 1118 |
intestine | 95% | 232.30 | 917 / 966 | 62% | 1.33 | 328 / 527 |
brain | 84% | 206.12 | 2217 / 2642 | 71% | 1.61 | 502 / 705 |
ovary | 93% | 202.18 | 167 / 180 | 54% | 1.17 | 234 / 430 |
prostate | 91% | 147.20 | 223 / 245 | 52% | 1.03 | 261 / 502 |
thymus | 96% | 207.49 | 624 / 653 | 47% | 0.89 | 282 / 605 |
pancreas | 98% | 688.16 | 320 / 328 | 43% | 0.73 | 77 / 178 |
kidney | 85% | 153.80 | 76 / 89 | 51% | 1.07 | 464 / 901 |
uterus | 95% | 214.79 | 161 / 170 | 42% | 0.75 | 193 / 459 |
adrenal gland | 86% | 213.47 | 221 / 258 | 47% | 1.24 | 109 / 230 |
bladder | 86% | 249.95 | 18 / 21 | 47% | 0.89 | 235 / 504 |
blood vessel | 96% | 379.33 | 1285 / 1335 | 0% | 0 | 0 / 0 |
adipose | 94% | 225.36 | 1137 / 1204 | 0% | 0 | 0 / 0 |
muscle | 93% | 496.36 | 745 / 803 | 0% | 0 | 0 / 0 |
spleen | 93% | 138.52 | 223 / 241 | 0% | 0 | 0 / 0 |
heart | 83% | 421.08 | 717 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 80% | 158.40 | 742 / 929 | 0% | 0 | 0 / 0 |
liver | 42% | 67.89 | 94 / 226 | 26% | 0.43 | 105 / 406 |
tonsil | 0% | 0 | 0 / 0 | 56% | 1.18 | 25 / 45 |
eye | 0% | 0 | 0 / 0 | 48% | 0.79 | 38 / 80 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.30 | 5 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0003140 | Biological process | determination of left/right asymmetry in lateral mesoderm |
GO_1900108 | Biological process | negative regulation of nodal signaling pathway |
GO_0160063 | Biological process | multi-pass transmembrane protein insertion into ER membrane |
GO_0005575 | Cellular component | cellular_component |
GO_0160064 | Cellular component | multi-pass translocon complex |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0043022 | Molecular function | ribosome binding |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NOMO3 |
Protein name | Nodal modulator 3 NOMO3 protein NODAL modulator 3 BOS complex subunit NOMO3 (Nodal modulator 3) (pM5 protein 3) |
Synonyms | |
Description | FUNCTION: Component of the multi-pass translocon (MPT) complex that mediates insertion of multi-pass membrane proteins into the lipid bilayer of membranes . The MPT complex takes over after the SEC61 complex: following membrane insertion of the first few transmembrane segments of proteins by the SEC61 complex, the MPT complex occludes the lateral gate of the SEC61 complex to promote insertion of subsequent transmembrane regions . . |
Accessions | A0A7I2V4D7 Q1LZN2 A0A7I2V2Z5 ENST00000633153.1 ENST00000677260.1 ENST00000611106.4 ENST00000677163.1 ENST00000678192.1 I3NI42 ENST00000678393.1 ENST00000576589.1 A0A7I2V686 ENST00000570346.1 ENST00000676550.1 ENST00000616708.4 ENST00000633882.1 ENST00000572033.1 I3L2X2 I3L1G6 ENST00000632143.1 I3L0Q6 ENST00000678538.1 ENST00000576460.5 J3KN36 A0A7I2V3P4 P69849 ENST00000676846.1 I3L516 ENST00000263012.10 A0A7I2V2V8 ENST00000619364.2 ENST00000677781.1 A0A7I2V6B0 ENST00000575225.5 ENST00000677777.1 ENST00000634143.1 A0A7I2V4T6 ENST00000399336.9 ENST00000677912.1 |